Published in Diabetologia on July 09, 2011
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients | NCT01687582
iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy. Cell Metab (2016) 1.41
Innate immune activation in obesity. Mol Aspects Med (2012) 0.99
Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology. Diabetologia (2011) 0.94
Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement (2014) 0.88
Glucagon-like peptide-1 analogues: An overview. Indian J Endocrinol Metab (2013) 0.87
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis. Ther Adv Endocrinol Metab (2014) 0.84
Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes. J Diabetes Investig (2013) 0.83
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacol Rev (2016) 0.78
The Crosstalk of Pathways Involved in Immune Response Maybe the Shared Molecular Basis of Rheumatoid Arthritis and Type 2 Diabetes. PLoS One (2015) 0.78
Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial. Trials (2016) 0.77
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. Mediators Inflamm (2016) 0.77
GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands. J Histochem Cytochem (2013) 0.77
Triggering drug use in patients with psoriasis: an investigative report from Turkey. Postepy Dermatol Alergol (2014) 0.75
GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine (2016) 0.75
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
The physiology of glucagon-like peptide 1. Physiol Rev (2007) 9.07
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation (2008) 4.22
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation (2004) 3.51
CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol (2008) 3.37
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res (2006) 2.67
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol (2007) 2.47
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol (2007) 2.40
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes (1995) 2.30
Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest (2002) 1.98
Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol (2009) 1.91
Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord (1993) 1.82
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol (2004) 1.73
Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol (2009) 1.70
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia (2011) 1.63
Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes (2008) 1.52
Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) (2008) 1.50
Therapeutic strategies based on glucagon-like peptide 1. Diabetes (2004) 1.39
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes (2011) 1.37
Retracted A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Diabetologia (2010) 1.33
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia (2010) 1.28
Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology (2007) 1.20
Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes (2008) 1.15
Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci (2000) 1.15
Continuous stimulation of human glucagon-like peptide-1 (7-36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia (2007) 1.12
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur J Pharmacol (2009) 1.10
Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res (2002) 1.09
Neuroprotective properties of GLP-1: theoretical and practical applications. Curr Med Res Opin (2011) 1.09
The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. Int Immunol (2009) 1.05
Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies. Am J Med (2011) 1.04
Circulating natural killer cells in psoriasis. Br J Dermatol (2003) 1.04
Mal mediates TLR-induced activation of CREB and expression of IL-10. J Immunol (2011) 1.03
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis (2008) 1.00
Distinct subsets of human invariant NKT cells differentially regulate T helper responses via dendritic cells. Eur J Immunol (2008) 0.97
Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J Nutr Biochem (2004) 0.96
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol (2008) 0.95
Gastric bypass surgery improves psoriasis. J Am Acad Dermatol (2010) 0.94
Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Ann N Y Acad Sci (2008) 0.94
Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum (2007) 0.93
The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions. Diabetes Metab (2008) 0.91
Immunopathogenesis of psoriasis: focus on natural killer T cells. J Eur Acad Dermatol Venereol (2009) 0.88
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans. Diabetes (2007) 0.88
Profound invariant natural killer T-cell deficiency in inflammatory arthritis. Ann Rheum Dis (2010) 0.88
Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity. Obes Surg (2011) 0.87
Glucagon-like peptide-1(1-37) inhibits chemokine-induced migration of human CD4-positive lymphocytes. Cell Mol Life Sci (2010) 0.85
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet (2004) 9.10
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods (1991) 4.64
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46
Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health (1993) 4.27
A case-control study of deaths from asthma. Thorax (1986) 3.97
Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart (2008) 3.73
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Myxomatosis. N Z Vet J (1985) 3.12
Role of methionine in the initiation of haemoglobin synthesis. Nature (1970) 3.02
Guidelines for clinical guidelines. BMJ (1998) 2.96
World War I may have allowed the emergence of "Spanish" influenza. Lancet Infect Dis (2002) 2.88
Impact of relational coordination on quality of care, postoperative pain and functioning, and length of stay: a nine-hospital study of surgical patients. Med Care (2000) 2.87
Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76
Patterns of physical activity among 11 to 16 year old British children. BMJ (1990) 2.75
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax (1996) 2.46
Effect of environmental factors on risk of injury of child pedestrians by motor vehicles: a case-control study. BMJ (1995) 2.41
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother (1995) 2.37
Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA (1976) 2.32
The lines of Blaschko: a review and reconsideration: Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol (1976) 2.28
Changing sex ratio in the United States, 1969-1995. Fertil Steril (1998) 2.23
Guidelines on preventing cardiovascular disease in clinical practice. BMJ (2000) 2.15
Pregnancy outcome at age 40 and older. Obstet Gynecol (1996) 2.09
Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med (1990) 2.04
Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med (1994) 2.01
Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions. Heart (2008) 2.00
Evaluations of children who have disclosed sexual abuse via facilitated communication. Arch Pediatr Adolesc Med (1994) 2.00
The role of driver sleepiness in car crashes: a systematic review of epidemiological studies. Accid Anal Prev (2001) 1.98
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Alcohol, cardiovascular diseases and all causes of death: a review of the epidemiological evidence. Drug Alcohol Rev (1992) 1.93
Community-acquired Klebsiella pneumoniae liver abscess: an emerging infection in Ireland and Europe. Infection (2013) 1.89
International, collaborative experience of 1789 patients having multifetal pregnancy reduction: a plateauing of risks and outcomes. J Soc Gynecol Investig (1996) 1.87
Nevoid basal cell carcinoma syndrome. Can Med Assoc J (1971) 1.87
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther (1996) 1.85
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol (1998) 1.84
The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol (1998) 1.78
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess (2012) 1.70
Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest (1998) 1.70
The epidemiology of Mycobacterium bovis infections. Vet Microbiol (1994) 1.69
Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg (2012) 1.67
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol (2005) 1.67
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci U S A (1996) 1.67
Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence. J Public Health (Oxf) (2010) 1.66
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65
Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife. Vet Microbiol (2008) 1.65
Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM (1997) 1.63
Prevalence of anthelmintic resistance on sheep farms in New Zealand. N Z Vet J (2006) 1.62
Motorcycle engine size and risk of moderate to fatal injury from a motorcycle crash. Accid Anal Prev (2000) 1.62
Brucellosis control in Tajikistan using Rev 1 vaccine: change in seroprevalence in small ruminants from 2004 to 2009. Vet Rec (2011) 1.60
Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study. Gastroenterology (1978) 1.60
Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr (1989) 1.58
CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc Natl Acad Sci U S A (1998) 1.58
Association of childhood leukemia with maternal age, birth order, and paternal occupation. A case-control study. Am J Epidemiol (1984) 1.57
The role of case management within a community support system: partnership with psychosocial rehabilitation. Community Ment Health J (1994) 1.57
Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res (1999) 1.57
Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density? Osteoporos Int (2009) 1.56
The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes (1981) 1.55
Tuberculosis in a free-living brown hare (Lepus europaeus occidentalis). N Z Vet J (1993) 1.54
Efficacy and side effects of magnesium sulfate and ritodrine as tocolytic agents. Am J Obstet Gynecol (1988) 1.54
High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol (1990) 1.53
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol (2002) 1.52
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol (1996) 1.51
An autopsy case review of 142 nonpenetrating (blunt) injuries of the aorta. J Trauma (1992) 1.50
The evidence base for the cost effectiveness of cardiac rehabilitation. Heart (1997) 1.50
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol (1992) 1.50
High and low exercisers among 14- and 15-year-old children. J Public Health Med (1994) 1.49
Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia (2010) 1.49
Identification of glucosyltransferase genes involved in sinapate metabolism and lignin synthesis in Arabidopsis. J Biol Chem (2000) 1.49
Ultrasonographic screening for the Down syndrome fetus. Am J Obstet Gynecol (1991) 1.48
Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase. Nat Struct Biol (1996) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut (2008) 1.47
Difficult airway management of a child impaled through the neck. Paediatr Anaesth (2001) 1.44
Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01) Br J Dermatol (2000) 1.43
Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases. Am J Obstet Gynecol (1994) 1.43
Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol (2012) 1.43
The use of the laryngeal mask airway to facilitate the insertion of a percutaneous tracheostomy. Intensive Care Med (1994) 1.42
The importance of being visually literate. Observations on the art and science of making a morphological diagnosis in dermatology. Arch Dermatol (1975) 1.42
Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis. Br J Dermatol (2010) 1.42
Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol (1998) 1.41
The enzymatic synthesis of hydroxymethyldihydropteridine pyrophosphate and dihydrofolate. Biochemistry (1969) 1.41
Pneumonic lesions in lambs in New Zealand: patterns of prevalence and effects on production. N Z Vet J (2004) 1.41
The neurotoxicity of inhaled toluene. Can J Psychiatry (1990) 1.41
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol (2005) 1.40
Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ (2000) 1.40
The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders. Heart (2000) 1.40
A comparison of performances of consultant surgeons, NCHDs and medical students in a modified HPAT examination. Ir Med J (2010) 1.40
Chorionic villus sampling before multifetal pregnancy reduction. Am J Obstet Gynecol (2000) 1.40
Prevalence of driver sleepiness in a random population-based sample of car driving. Sleep (2001) 1.39
Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci (1994) 1.39
An independent pilot study into the accuracy and reliability of home blood glucose monitors. Lancet (1999) 1.39